{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:10:45Z","timestamp":1773659445851,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.yebeh.2019.106723","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T12:20:12Z","timestamp":1575289212000},"page":"106723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Factors associated with obsessive\u2013compulsive symptoms in people with epilepsy"],"prefix":"10.1016","volume":"102","author":[{"given":"Soo Jeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Ahm","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Uk","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Hyun","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gha-hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Deog","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Bin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.106723_bb0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(02)09620-4","article-title":"Obsessive\u2013compulsive disorder","volume":"360","author":"Stein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2019.106723_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11920-019-1015-2","article-title":"Epidemiological and clinical gender differences in OCD","volume":"21","author":"Mathes","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.yebeh.2019.106723_bb0015","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.yebeh.2009.01.016","article-title":"A comparative study of obsessive\u2013compulsive disorder and other psychiatric comorbidities in patients with temporal lobe epilepsy and idiopathic generalized epilepsy","volume":"14","author":"Ertekin","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106723_bb0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yebeh.2005.07.003","article-title":"Obsessionality, obsessive\u2013compulsive disorder, and temporal lobe epilepsy","volume":"7","author":"Monaco","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106723_bb0025","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.yebeh.2019.106723_bb0030","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1528-1167.2009.02387.x","article-title":"Factors contributing to depression in patients with epilepsy","volume":"51","author":"Lee","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106723_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3988\/jcn.2014.10.2.125","article-title":"Obsessive\u2013compulsive symptoms and their impacts on psychosocial functioning in people with epilepsy","volume":"10","author":"Seo","year":"2014","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.yebeh.2019.106723_bb0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.yebeh.2013.01.022","article-title":"Psychopathological and peripheral levels of neurobiological correlates of obsessive\u2013compulsive symptoms in patients with epilepsy: a hospital-based study","volume":"27","author":"Hamed","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106723_bb0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.seizure.2010.07.004","article-title":"Psychiatric disorders in temporal lobe epilepsy: an overview from a tertiary service in Brazil","volume":"19","author":"de Oliveira","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.106723_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jad.2014.05.015","article-title":"Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial","volume":"166","author":"Sahraian","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.yebeh.2019.106723_bb0055","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1503\/jpn.150100","article-title":"Topiramate augmentation in a patient with obsessive\u2013compulsive disorder","volume":"40","author":"Van Ameringen","year":"2015","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.yebeh.2019.106723_bb0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2174\/1570159X15666170320104237","article-title":"Glutamate-modulating drugs as a potential therapeutic strategy in obsessive\u2013compulsive disorder","volume":"15","author":"Marinova","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.yebeh.2019.106723_bb0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106723_bb0070","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106723_bb0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106723_bb0080","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1037\/1040-3590.14.4.485","article-title":"The Obsessive\u2013Compulsive Inventory: development and validation of a short version","volume":"14","author":"Foa","year":"2002","journal-title":"Psychol Assess"},{"key":"10.1016\/j.yebeh.2019.106723_bb0085","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3349\/ymj.2008.49.6.909","article-title":"Reliability and validity of the Korean version of Obsessive\u2013Compulsive Inventory-Revised in a non-clinical sample","volume":"49","author":"Lim","year":"2008","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.yebeh.2019.106723_bb0090","first-page":"289","article-title":"A study on the standardization of the hospital anxiety and depression scale for Koreans: a comparison of normal, depressed and anxious groups","volume":"38","author":"Oh","year":"1999","journal-title":"J Korean Neuropsychiatr Assoc"},{"key":"10.1016\/j.yebeh.2019.106723_bb0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.yebeh.2019.106723_bb0100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1528-1157.2002.32901.x","article-title":"Syndromic diagnosis at the epilepsy clinic: role of MRI in lobar epilepsies","volume":"43","author":"Lee","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106723_bb0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1528-1157.1999.tb00738.x","article-title":"Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement","volume":"40","author":"Berg","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106723_bb0110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.yebeh.2005.02.010","article-title":"Association of temporal lobe epilepsy and obsessive\u2013compulsive disorder in a patient successfully treated with right temporal lobectomy","volume":"6","author":"Barbieri","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106723_bb0115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.yebeh.2011.07.029","article-title":"Obsessive\u2013compulsive disorder in chronic epilepsy","volume":"22","author":"Kaplan","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106723_bb0120","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S1092852912000065","article-title":"Topiramate augmentation in resistant OCD: a double-blind placebo-controlled clinical trial","volume":"15","author":"Mowla","year":"2010","journal-title":"CNS Spectr"},{"key":"10.1016\/j.yebeh.2019.106723_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/JCP.0b013e31824929d6","article-title":"The psychopharmacology of aggressive behavior: a translational approach part 2 clinical studies using atypical antipsychotics, anticonvulsants, and lithium","volume":"32","author":"Comai","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.yebeh.2019.106723_bb0130","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2019.106723_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.yebeh.2019.106723_bb0140","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.08.008","article-title":"Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study","volume":"61","author":"McElroy","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2019.106723_bb0145","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.conb.2011.04.010","article-title":"Neurobiology of obsessive\u2013compulsive disorder: insights into neural circuitry dysfunction through mouse genetics","volume":"21","author":"Ting","year":"2011","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.yebeh.2019.106723_bb0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eurpsy.2004.09.015","article-title":"Topiramate related obsessive\u2013compulsive disorder","volume":"20","author":"Ozkara","year":"2005","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.yebeh.2019.106723_bb0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1440-1819.2006.01520.x","article-title":"Topiramate may induce obsessive\u2013compulsive disorder","volume":"60","author":"Thuile","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2019.106723_bb0160","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1177\/0269881111431751","article-title":"Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive\u2013compulsive disorder: a double-blind, placebo-controlled study","volume":"26","author":"Bruno","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.yebeh.2019.106723_bb0165","first-page":"104","article-title":"Lamotrigine augmentation versus placebo in serotonin reuptake inhibitors-resistant obsessive\u2013compulsive disorder: a randomized controlled trial","volume":"11","author":"Khalkhali","year":"2016","journal-title":"Iran J Psychiatry"},{"key":"10.1016\/j.yebeh.2019.106723_bb0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1017\/S1092852900020617","article-title":"An association of intrusive, repetitive phrases with lamotrigine treatment in bipolar II disorder","volume":"12","author":"Kemp","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1016\/j.yebeh.2019.106723_bb0175","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1017\/S1092852918001049","article-title":"Lamotrigine-induced obsessive\u2013compulsive disorder in patients with bipolar disorder","volume":"24","author":"Sharma","year":"2019","journal-title":"CNS Spectr"},{"key":"10.1016\/j.yebeh.2019.106723_bb0180","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00003495-199550040-00008","article-title":"Lamotrigine","volume":"50","author":"Fitton","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2019.106723_bb0185","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopha.2016.05.035","article-title":"Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test","volume":"82","author":"Ostadhadi","year":"2016","journal-title":"Biomed Pharmacother"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019310741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019310741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:31:10Z","timestamp":1761503470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019310741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":37,"alternative-id":["S1525505019310741"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106723","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with obsessive\u2013compulsive symptoms in people with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106723"}}